Technetium Tc 99m Sestamibi
"Technetium Tc 99m Sestamibi" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A technetium imaging agent used to reveal blood-starved cardiac tissue during a heart attack.
| Descriptor ID |
D017256
|
| MeSH Number(s) |
D02.626.872 D02.691.825.937
|
| Concept/Terms |
Technetium Tc 99m Sestamibi- Technetium Tc 99m Sestamibi
- Tc-99m-Methoxy-2-isobutylisonitrile
- Tc 99m Methoxy 2 isobutylisonitrile
- Technetium-99m-Hexamibi
- Technetium 99m Hexamibi
- Tc MIBI
- 99mTc-Hexamibi
- 99mTc Hexamibi
- 99mTc-Sestamibi
- 99mTc Sestamibi
- Technetium Tc 99m 2-Methoxy-2-methylpropylisonitrile
- Technetium Tc 99m 2 Methoxy 2 methylpropylisonitrile
- Technetium-99m-Sestamibi
- Technetium 99m Sestamibi
|
Below are MeSH descriptors whose meaning is more general than "Technetium Tc 99m Sestamibi".
Below are MeSH descriptors whose meaning is more specific than "Technetium Tc 99m Sestamibi".
This graph shows the total number of publications written about "Technetium Tc 99m Sestamibi" by people in this website by year, and whether "Technetium Tc 99m Sestamibi" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 2 | 5 |
| 1995 | 2 | 0 | 2 |
| 1996 | 4 | 2 | 6 |
| 1997 | 3 | 2 | 5 |
| 1998 | 2 | 3 | 5 |
| 1999 | 1 | 2 | 3 |
| 2000 | 6 | 4 | 10 |
| 2001 | 1 | 2 | 3 |
| 2002 | 4 | 3 | 7 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 4 | 2 | 6 |
| 2006 | 1 | 2 | 3 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 1 | 1 | 2 |
| 2014 | 1 | 2 | 3 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Technetium Tc 99m Sestamibi" by people in Profiles.
-
Editorial Comment: Value-Added Assessment for Parathyroid Adenomas on Routine CT Examinations. AJR Am J Roentgenol. 2023 Aug; 221(2):226.
-
Monte Carlo-derived 99m Tc uptake quantification with commercial planar MBI: Absolute tumor activity. Med Phys. 2023 May; 50(5):2985-2997.
-
Efficacy of myocardial washout of 99mTc-MIBI/Tetrofosmin for the evaluation of inflammation in patients with cardiac sarcoidosis: comparison with 18F-fluorodeoxyglucose positron emission tomography findings. Ann Nucl Med. 2022 Jun; 36(6):544-552.
-
Advances and Future Directions in Molecular Breast Imaging. J Nucl Med. 2022 Jan; 63(1):17-21.
-
American Head and Neck Society Endocrine Surgery Section update on parathyroid imaging for surgical candidates with primary hyperparathyroidism. Head Neck. 2019 07; 41(7):2398-2409.
-
Solitary Parathyroid Adenoma Localization in Technetium Tc99m Sestamibi SPECT and Multiphase Multidetector 4D CT. AJNR Am J Neuroradiol. 2019 01; 40(1):142-149.
-
FMTVDM-TFM??: True quantification requires standardization of the tool being used to measure, with a known, unchanging standard to produce accurate, consistent and reproducible quantified measurements. J Nucl Cardiol. 2019 Oct; 26(5):1780-1783.
-
IMAGING LOCALIZATION AND SURGICAL APPROACH IN THE MANAGEMENT OF ECTOPIC PARATHYROID ADENOMAS. Endocr Pract. 2018 Jun; 24(6):589-598.
-
The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma. Eur J Radiol. 2017 Oct; 95:82-88.
-
99mTc Sestamibi Thyroid Scan in Amiodarone-Induced Thyrotoxicosis Type I. Clin Nucl Med. 2016 Jul; 41(7):566-7.